Benchmark indices continued to consolidate in afternoon after hitting life-time highs.
The 30-share BSE Sensex was up 36.33 points at 34,046.94 and the 50-share NSE Nifty rose 1.30 points to 10,532.80.
About 1,422 shares advanced against 1,094 declining shares on the BSE.
Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep vein thrombosis.
For more information ✆ – 0731-6642300 or visit- http://www.epicresearch.co/festive-offers
You may also like:
|Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited||Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed|